Cardiovascular Business March 23, 2023
In her research at Mayo, Pellikka has been involved with the development of AI that looks at the ultrasound images to directly detect disease. The algorithms can pick out radiomic signatures of disease in the image that may not be evident to the human eye. “I think the potential there is enormous,” Pellikka said.
She collaborated with the AI vendor Ultromics on its EchoGo algorithms to detect heart failure patients with preserved ejection fraction (HFpEF) by looking at a single apical four-chamber view. HFpEF can be difficult to detect, and this is the first AI cleared to detect it, filling an unmet need. The technology received the FDA’s breakthrough device designation and was then cleared by the FDA at the...